Filter
8135
Filtered Results: 8135
Text search:
medicines
use
Featured
Recommendations
725
New Publications
2002
Language
Document type
No document type
4411
Studies & Reports
1455
Guidelines
1072
Manuals
416
Strategic & Response Plan
251
Fact sheets
194
Training Material
157
Situation Updates
71
Resource Platforms
34
Brochures
28
Infographics
23
Online Courses
16
Videos
5
App
2
Countries / Regions
India
382
Global
311
Kenya
227
South Africa
195
Ethiopia
164
Uganda
151
Nepal
146
Western and Central Europe
144
Africa
144
Sierra Leone
141
Nigeria
136
Liberia
128
Malawi
116
Latin America and the Carribbean
115
Tanzania
113
Bangladesh
112
Zambia
102
Myanmar / Burma
100
Ukraine
96
Ghana
89
Syria
86
Rwanda
86
Congo, Democratic Republic of
66
Philippines
66
Eastern Europe
62
Namibia
58
Russia
58
Zimbabwe
55
Brazil
54
South–East Asia Region
52
Mozambique
50
Asia
43
West and Central Africa
41
Lesotho
40
East and Southern Africa
40
Germany
39
Venezuela
39
Guinea
37
Senegal
37
Cambodia
37
Indonesia
37
Middle East and North Africa
37
South Sudan
36
Burkina Faso
35
Haiti
34
Cameroon
30
Yemen
30
Botswana
27
Eastern Europe and Central Asia
25
Colombia
23
Eswatini/ Swaziland
22
Benin
21
Peru
20
USA
18
Sudan
18
Pakistan
17
Afghanistan
17
Lebanon
17
Thailand
16
Madagascar
16
Vietnam
16
Paraguay
15
Mali
14
Western Pacific Region
14
Jordan
13
China
13
Ecuador
13
Moldova
13
Bolivia
12
Sri Lanka
12
Somalia
11
Central African Republic
11
Chile
11
Tajikistan
11
Georgia
10
North America
10
Angola
9
Albania
9
Southern Africa
9
Côte d’Ivoire / Ivory Coast
8
Iraq
8
North Macedonia
8
Mexico
8
Laos
8
United Kingdom
8
Spain
8
Palestine
7
Kyrgyzstan
7
Niger
6
Egypt
6
Argentina
6
Libya
6
Iran
6
Kazakhstan
6
Saudi Arabia
5
Turkey
5
Papua New Guinea
5
Poland
5
Jamaica
5
Belarus
5
Guinea-Bissau
4
Morocco
4
Chad
4
Hungary
4
Burundi
4
El Salvador
4
Guatemala
4
Bhutan
4
Canada
4
Estonia
4
Portugal
4
Gambia
3
Malaysia
3
Serbia
3
Greece
3
Nicaragua
3
Fiji
3
Armenia
3
Timor Leste/ East Timor
3
Qatar
3
Romania
3
Japan
3
France
3
Mauritius
3
Tunisia
3
Togo
2
Mauritania
2
Honduras
2
Other region
2
Mongolia
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Uzbekistan
2
Australia
2
Gabon
2
Turkmenistan
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Singapore
1
Switzerland
1
Solomon Islands
1
Italy
1
Djibouti
1
Slovakia
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2969
Clinical Guidelines
675
Public Health
474
Women & Child Health
374
Key Resources
245
Capacity Building
170
Pharmacy & Technologies
93
Annual Report MEDBOX
3
Toolboxes
COVID-19
727
Mental Health
711
HIV
647
TB
465
AMR
352
Caregiver
252
Disability
250
Pharmacy
241
NCDs
231
Planetary Health
228
NTDs
210
Ebola
206
Rapid Response
187
Conflict
185
Refugee
152
Global Health Education
118
Natural Hazards
77
Health Financing Toolbox
63
Zika
51
Specific Hazards
41
Social Ethics
40
Cholera
27
Polio
22
Health Financing
2
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human ... (WHO CIA List). These guidelines aim primarily to help preserve the effectiveness of medically important antimicrobials, particularly those antimicrobials judged to be critically important to human medicine and also help preserve the effectiveness of antimicrobials for veterinary medicine, in direct support of the WHO global action plan on antimicrobial resistance
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, ...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing h...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of essential medicines and development of ess...
All WHO essential medicines are covered in Wikipedia: https://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines, and items are translated in several languages. Increasing the amount, quali...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality ... for the population. To fulfill its mandate, DPMED aims to strengthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Antimicrobial resistance (AMR) represents a major threat to human health with significant global economic and security implications. In 2015, WHO Member States unanimously approved a Global Action Plan to tackle AMR (GAP-AMR). The goal of GAP-AMR is “to ensure, for as long as possible, continuity ...
Background
Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension ... to identify areas for improvement in access to medication treatment.
Methods and Results
We used the World Health Organization online repository of national essential medicines lists (EMLs) for 53 countries to transcribe the information on the inclusion of 12 cardiovascular disease/hypertension medications within each country's essential medicines list. Data on availability, price, and affordability were obtained from 84 surveys in 59 countries that used the World Health Organization's Health Action International survey methodology. We summarized and compared the indicators across lowest‐price generic and originator brand medicines in the public and private sectors and by country income groups. The average availability of the select medications was 54% in low‐ and lower‐middle‐income countries and 60% in high‐ and upper‐middle‐income countries, and was higher for generic (61%) than brand medicines (41%). The average patient median price ratio was 80.3 for brand and 16.7 for generic medicines and was higher for patients in low‐ and lower‐middle‐income countries compared with high‐ and upper‐middle‐income countries across all medicine categories. The costs of 1 month's antihypertensive medications were, on average, 6.0 days’ wage for brand medicine and 1.8 days’ wage for generics. Affordability was lower in low‐ and lower‐middle‐income countries than high‐ and upper‐middle‐income countries for both brand and generic medications.
Conclusions
The availability and accessibility of pharmaceuticals is an ongoing challenge for health systems. Low availability and high costs are major barriers to the use of and adherence to essential cardiovascular disease and antihypertensive medications worldwide, particularly in low‐ and lower‐middle‐income countries.
In May 2015, the Sixty-eighth World Health Assembly recognized the importance of the public health problem posed by antimicrobial resistance by adopting the global action plan on antimicrobial resistance (“global action plan”). The global action plan proposes interve...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the ... Utilisation Research in Africa (MURIA).
Point Prevalence Surveys collects information on prescribing practices of antibiotics and other information relevant to treatment and management of infectious diseases in hospitalized patients, and complements surveillance of antimicrobial consumption.
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonizatio...
This policy document is to guide the Traditional, Complimentary and Alternative Medicine practices in Rwanda. The various elements examined under the policy include, legislation and regulatory control, registration, manufacture, procurement and supp...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of...
Afr J Tradit Complement Altern Med. (2013) 10(5):210-229
Plants are important sources of medicines. Herbal medicines in Lesotho are exposed to excessive exploitation and habitat destruction. C...
Plants are important sources of medicines. Herbal medicines in Lesotho are exposed to excessive exploitation and habitat destruction. C...
